Nomura Asset Management
VRTX icon

Nomura Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$70.7M Buy
158,916
+5,621
+4% +$2.5M 0.19% 112
2025
Q1
$74.3M Buy
153,295
+3,496
+2% +$1.69M 0.23% 100
2024
Q4
$60.3M Sell
149,799
-5,095
-3% -$2.05M 0.18% 119
2024
Q3
$72M Buy
154,894
+6,831
+5% +$3.18M 0.22% 100
2024
Q2
$69.4M Buy
148,063
+16,701
+13% +$7.83M 0.24% 87
2024
Q1
$54.9M Sell
131,362
-19,353
-13% -$8.09M 0.2% 115
2023
Q4
$61.3M Sell
150,715
-18,822
-11% -$7.66M 0.25% 90
2023
Q3
$59M Buy
169,537
+3,852
+2% +$1.34M 0.28% 77
2023
Q2
$58.3M Sell
165,685
-19,008
-10% -$6.69M 0.27% 87
2023
Q1
$58.2M Sell
184,693
-111,826
-38% -$35.2M 0.31% 76
2022
Q4
$85.6M Sell
296,519
-22,660
-7% -$6.54M 0.5% 40
2022
Q3
$92.4M Buy
319,179
+6,227
+2% +$1.8M 0.59% 32
2022
Q2
$88.2M Sell
312,952
-2,052
-0.7% -$578K 0.55% 37
2022
Q1
$82.2M Buy
315,004
+18,150
+6% +$4.74M 0.45% 43
2021
Q4
$65.2M Buy
296,854
+56,197
+23% +$12.3M 0.33% 70
2021
Q3
$43.7M Buy
240,657
+12,681
+6% +$2.3M 0.25% 100
2021
Q2
$46M Sell
227,976
-11,180
-5% -$2.25M 0.27% 89
2021
Q1
$51.4M Sell
239,156
-11,802
-5% -$2.54M 0.33% 73
2020
Q4
$59.3M Buy
250,958
+10,907
+5% +$2.58M 0.4% 60
2020
Q3
$65.3M Buy
240,051
+57,031
+31% +$15.5M 0.5% 43
2020
Q2
$53.1M Buy
183,020
+12,100
+7% +$3.51M 0.45% 52
2020
Q1
$40.7M Buy
170,920
+113,007
+195% +$26.9M 0.42% 57
2019
Q4
$12.7M Sell
57,913
-3,556
-6% -$779K 0.11% 185
2019
Q3
$10.4M Buy
61,469
+3,536
+6% +$599K 0.1% 213
2019
Q2
$10.6M Sell
57,933
-352
-0.6% -$64.6K 0.11% 192
2019
Q1
$10.7M Sell
58,285
-1,358
-2% -$250K 0.11% 183
2018
Q4
$9.88M Buy
59,643
+3,539
+6% +$586K 0.11% 183
2018
Q3
$10.8M Buy
56,104
+716
+1% +$138K 0.1% 170
2018
Q2
$9.41M Sell
55,388
-1,428
-3% -$243K 0.1% 187
2018
Q1
$9.26M Buy
56,816
+1,193
+2% +$194K 0.1% 174
2017
Q4
$8.34M Buy
55,623
+23,823
+75% +$3.57M 0.1% 188
2017
Q3
$4.84M Sell
31,800
-21,390
-40% -$3.25M 0.06% 273
2017
Q2
$6.86M Buy
53,190
+1,474
+3% +$190K 0.09% 212
2017
Q1
$5.66M Buy
51,716
+14,699
+40% +$1.61M 0.08% 251
2016
Q4
$2.73M Sell
37,017
-15,579
-30% -$1.15M 0.05% 348
2016
Q3
$4.59M Buy
52,596
+860
+2% +$75K 0.08% 254
2016
Q2
$4.45M Buy
51,736
+15,281
+42% +$1.31M 0.08% 241
2016
Q1
$2.9M Buy
36,455
+7,783
+27% +$618K 0.06% 317
2015
Q4
$3.61M Sell
28,672
-6,063
-17% -$763K 0.07% 266
2015
Q3
$3.62M Buy
34,735
+1,365
+4% +$142K 0.07% 262
2015
Q2
$4.12M Sell
33,370
-3,875
-10% -$479K 0.08% 251
2015
Q1
$4.39M Buy
37,245
+3,455
+10% +$408K 0.08% 238
2014
Q4
$4.03M Buy
33,790
+6,949
+26% +$828K 0.07% 259
2014
Q3
$3.02M Buy
26,841
+1,678
+7% +$188K 0.05% 299
2014
Q2
$2.38M Buy
25,163
+145
+0.6% +$13.7K 0.04% 342
2014
Q1
$1.77M Sell
25,018
-9,130
-27% -$646K 0.03% 406
2013
Q4
$2.54M Buy
34,148
+8,410
+33% +$625K 0.05% 333
2013
Q3
$1.95M Sell
25,738
-7,432
-22% -$563K 0.04% 379
2013
Q2
$2.65M Buy
+33,170
New +$2.65M 0.05% 348